SCHEMBL18178642

SCHEMBL18178642

CCC(=O)Oc1cccc(Br)c1COc1cc(Cl)c(C)cc1F

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
MRGPRX4 Q96LA9 5/20 0.35
PTGER1 P34995 1/20 0.35
ACHE P22303 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK14 Q16539 1/20 0.34
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178693 0.91 MRGPRX4 (0.38) MAPTMRGPRX4PTGER1ACHEALDH1A1
SCHEMBL18178547 0.90 MRGPRX4 (0.40) MAPTMRGPRX4PTGER1ACHEALDH1A1
SCHEMBL18530975 0.90 MAPT (0.40) MAPTMRGPRX4ACHEALDH1A1LMNA
SCHEMBL18178654 0.90 MAPT (0.38) MAPTMRGPRX4ACHEALDH1A1LMNA
SCHEMBL18178660 0.90 MAPT (0.38) MAPTMRGPRX4ACHEALDH1A1LMNA
SCHEMBL18178639 0.90 ALDH1A1 (0.39) MAPTMRGPRX4ACHEALDH1A1
SCHEMBL18178640 0.90 SLC22A12 (0.39) MAPTMRGPRX4ACHEALDH1A1LMNA
SCHEMBL18178638 0.90 ALDH1A1 (0.39) MAPTMRGPRX4ACHEALDH1A1
SCHEMBL18178245 0.89 LMNA (0.37) MAPTMRGPRX4PTGER1ALDH1A1MAPK14
SCHEMBL18183030 0.89 MRGPRX4 (0.37) MAPTMRGPRX4PTGER1ALDH1A1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 MAPT 4572/4885MRGPRX4 167/4885PTGER1 4234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.